Lundbeck
HLUN-B.CO
#2744
Rank
โ‚น613.66 B
Marketcap
โ‚น618.52
Share price
-0.80%
Change (1 day)
29.37%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2026 (TTM): โ‚น66.83

According to Lundbeck's latest financial reports the company's current EPS (TTM) is โ‚น72.45. In 2025 the company made an earnings per share (EPS) of โ‚น48.90 an increase over its 2024 EPS that were of โ‚น42.71.

EPS history for Lundbeck from 2004 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น66.8336.66%
2025โ‚น48.9014.5%
2024โ‚น42.7129.29%
2023โ‚น33.0323.09%
2022โ‚น26.8437.26%
2021โ‚น19.55-84.61%
2020โ‚น127.05-24.61%
2019โ‚น168.52-42.06%
2018โ‚น290.8540.7%
2017โ‚น206.73146.26%
2016โ‚น83.95-120.48%
2015-โ‚น409.803231.32%
2014-โ‚น12.30-115.78%
2013โ‚น77.95-23.36%
2012โ‚น101.70-48.01%
2011โ‚น195.64-9.68%
2010โ‚น216.6213.72%
2009โ‚น190.4724.32%
2008โ‚น153.22-6.05%
2007โ‚น163.0881.77%
2006โ‚น89.72-16.76%
2005โ‚น107.79-17.58%
2004โ‚น130.78